Please Wait
Applying Filters...
menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Amikacin Sulfate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 154Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of August 25, 2021
    Enforcement Report - Week of August 25, 2021

    25 Aug 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

    FDA
    25 Aug 2021
    Share Share
    Morton Grove's Withdrawal of Approval of 21 Abbreviated New Drug Applications
    Morton Grove's Withdrawal of Approval of 21 Abbreviated New Drug Applications

    02 Dec 2019

    // FEDERALREGISTER

    https://www.federalregister.gov/documents/2019/12/02/2019-25946/morton-grove-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-21-abbreviated-new-drug

    FEDERALREGISTER
    02 Dec 2019
    Share Share
    Emcure schizophrenia drug recalled after contamination spotted
    Emcure schizophrenia drug recalled after contamination spotted

    29 May 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/emcure-injected-schizophrenia-drug-recalled-after-contamination-detected

    Eric Palmer FIERCE PHARMA
    29 May 2019
    Share Share
    Heritage Pharma Issues Recall of Amikacin Sulfate & Prochlorperazine Edisylate
    Heritage Pharma Issues Recall of Amikacin Sulfate & Prochlorperazine Edisylate

    28 May 2019

    // PR NEWSWIRE

    https://www.pharmacompass.com/pdf/news/heritage-pharma-issues-recall-of-amikacin-sulfate-prochlorperazine-edisylate-1559107374.pdf

    PR NEWSWIRE
    28 May 2019
    Share Share
    Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of 7 Lots of Amikacin
    Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of 7 Lots of Amikacin

    02 Aug 2016

    // FDA

    http://www.fda.gov/Safety/Recalls/ucm514656.htm

    FDA
    02 Aug 2016
    Share Share
    US FDA Enforcement Report- 1/June/2016
    US FDA Enforcement Report- 1/June/2016

    31 May 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-1june2016-1464785216.pdf

    FDA
    31 May 2016
    Share Share